Please assess the completion status of the following clinical trial:

Trial Title: In Vivo Hip Fracture Discrimination With Quantitative Computed Tomography (QCT)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~Selection of cases: women with hip fracture~* woman aged 60 years and more~* clinical suspicion of osteoporosis based on the following: trivial trauma (fall from the standing position), history of vertebral fracture or visualization of a vertebral fracture by CT~* availability of radiographs of the proximal femur (anteroposterior view of the pelvis mandatory; anteroposterior and lateral views of the fractured hip optional)~* signature by the patient of the informed consent document~Exclusion criteria:~* patient under 60 years~* current bisphosphonate, oestrogen, or SERM treatment started more than 3 months earlier; or past treatment with these medications stopped less than 6 months earlier~* hip arthroplasty on the other side~* fracture at the site of a bone lesion~* psychiatric disorder that might prevent the patient from giving informed consent or from remaining completely still for about 15 minutes during the investigations~* informed consent document not signed by the patient~Selection of controls:~The controls will be women without hip fracture matched on age to the cases.~Inclusion criteria:~* woman aged 60 years and more~* signature by the patient of the informed consent document~Exclusion criteria:~* age under 60 years~* male~* current bisphosphonate, oestrogen, or SERM therapy started more than 3 months earlier; or past treatment with these medications stopped less than 6 months earlier~* history of osteoporotic hip fracture.~* psychiatric disorder that might prevent the patient from giving informed consent or from remaining completely still for about 15 minutes during the investigations~* informed consent document not signed by the patient

- Gender: FEMALE
- Minimum Age: 60 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Control (Type: None): Women without hip fracture, matched on age to the cases
- Patient (Type: None): Female patients aged 60 and older with hip fracture

Based on this trial design, predict the completion outcome and termination type (if applicable).